BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Hippocampus
,
Personalized medicine
,
Prozac
,
rs7903146
,
PBX1
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
apo c- iii
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
O-glycoprofiling of Serum Apolipoprotein C-III in Colorectal Cancer.
Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.
Recent Apolipoprotein CIII trials.
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-II…
Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling b…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
Type III Dysbetalipoproteinemia
AZD0585 Phase III Long-term Study in Japan
Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ